TrialEuropean heart journal2020

A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial.

Alexander J M Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.